Norway
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
21.24%
|
Dec. 31, 2023 | USD 1.26 | -2.20% |
|
Norway |
|
2 |
16.84%
|
Dec. 31, 2024 | USD 17.56 | 0.15% |
|
Norway |
|
3 |
7.20%
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
4 |
4.92%
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
5 |
-6.97%
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
6 |
-54.91%
|
Dec. 31, 2023 | USD 0.27 | 1.85% |
|
Norway |
|
7 |
-270.12%
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
8 |
-339.96%
|
Dec. 31, 2023 | USD 0.23 | -0.24% |
|
Norway |
|
9 |
-743.85%
|
Dec. 31, 2023 | USD 0.11 | -0.62% |
|
Norway |
|
10 |
-53,622.32%
|
Dec. 31, 2023 | USD 0.73 | 3.02% |
|
Norway |
The Biotechnology company in Norway with the highest EBIT Margin is ArcticZymes Technologies ASA (Oslo Stock Exchange: AZT.OL) at 21.24%.
The Biotechnology company in Norway with the lowest EBIT Margin is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at -53,622.32%.
The top 10 Biotechnology companies in Norway by EBIT Margin are ArcticZymes Technologies ASA, Borregaard ASA, Photocure ASA, Navamedic ASA, Gentian Diagnostics ASA, Hofseth BioCare ASA, Lifecare AS, Nykode Therapeutics AS, PCI Biotech Holding ASA and BerGenBio ASA.
The bottom 10 Biotechnology companies in Norway by EBIT Margin are BerGenBio ASA, PCI Biotech Holding ASA, Nykode Therapeutics AS, Lifecare AS, Hofseth BioCare ASA, Gentian Diagnostics ASA, Navamedic ASA, Photocure ASA, Borregaard ASA and ArcticZymes Technologies ASA.